scispace - formally typeset
F

Fergus Shanahan

Researcher at National University of Ireland

Publications -  727
Citations -  59181

Fergus Shanahan is an academic researcher from National University of Ireland. The author has contributed to research in topics: Inflammatory bowel disease & Gut flora. The author has an hindex of 117, co-authored 705 publications receiving 51963 citations. Previous affiliations of Fergus Shanahan include Imperial College London & Mater Misericordiae Hospital.

Papers
More filters
Journal ArticleDOI

Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation

TL;DR: This report demonstrates the strategic localisation and upregulation of NK-1R expression in IBD colon, and thereby suggests the involvement of substance P in the pathophysiological symptoms of IBD.
Journal ArticleDOI

Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors.

TL;DR: IBS and major depression are characterized by a pro-inflammatory profile, whereas IBS patients alone exhibit an exaggerated muscarinic receptor-mediated IL-6 response.
Journal Article

Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis

TL;DR: Dysplasia surveillance colonoscopy in ulcerative colitis is not a well standardized, clearly understood screening tool, and continued education of the gastroenterology community regarding its outcomes and pitfalls is needed.
Journal ArticleDOI

Exercise and the microbiota

TL;DR: The relationship between extreme levels of exercise, associated dietary habits and gut microbiota composition are assessed, and potential mechanisms by which exercise may exert a direct or indirect influence on gut microbiota are discussed.
Journal ArticleDOI

Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis.

TL;DR: Ileal pouch-anal anastomosis remains the “gold standard” in surgical treatment of ulcerative colitis and familial adenomatous polyposis and sulfate-reducing bacteria are exclusive to patients with a background of ulcersated colitis.